|Trade names||(none, active metabolite of Rilmazafone)|
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|3D model (JSmol)|
Rilmazolam, is a benzodiazepine derivative which acts as a sedative and hypnotic drug, and the active metabolite of the drug Rilmazafone. It has never been developed for medical uses, yet the aforementioned prodrug is an approved medication in Japan.